Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma

Clinical Drug Investigation, vol. 42, pp. 283

Authors 9

1. Baek‐Yeol Ryoo corresponding

   Asan Medical Center · University of Ulsan

   Affiliation as printed

   Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. ryooby@amc.seoul.kr

   Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

2. Daniel H. Palmer

   Liverpool Experimental Cancer Medicine Centre

   Affiliation as printed

   Liverpool CR UK/NIHR Experimental Cancer Medicine Centre, and The Clatterbridge Cancer Centre, Liverpool, UK

3. Sook Ryun Park

   Asan Medical Center · University of Ulsan

   Affiliation as printed

   Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

4. Lorenza Rimassa

   Humanitas University · IRCCS Humanitas Research Hospital

   Affiliation as printed

   Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

   Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy

5. Debashis Sarker

   King's College London

   Affiliation as printed

   School of Cancer and Pharmaceutical Sciences, King's College London, London, UK

6. Bruno Daniele

   Regione Campania · Azienda Ospedaliera G.Rummo

   Affiliation as printed

   Department of Oncology, G. Rummo Hospital, Benevento, Italy

   Oncology Unit, Ospedale del Mare, Naples, Italy

7. Joyce Steinberg

   Astellas Pharma (United States)

   Affiliation as printed

   Astellas Pharma Inc., Northbrook, IL, USA

8. Beatriz López Aachen Data Science Quantitative Sciences

   Janssen (Netherlands) · Astellas Pharma (Netherlands)

   Affiliation as printed

   Data Science, Astellas Pharma Inc., Leiden, The Netherlands

   Quantitative Sciences, Janssen R&D, Janssen Pharmaceutical Companies of Johnson & Johnson, Leiden, The Netherlands

9. Ho Yeong Lim

   Samsung Medical Center · Sungkyunkwan University

   Affiliation as printed

   Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea